HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kyogo Itoh Selected Research

Peptides (Polypeptides)

6/2022Immune responses of patients without cancer recurrence after a cancer vaccine over a long term.
8/2021Plasma level of prostate related-antigen peptide-reactive IgG is a prognostic factor of patients with breast cancer treated with personalized peptide vaccines.
2/2021Investigation of factors associated with reduced clinical benefits of personalized peptide vaccination for pancreatic cancer.
1/2021A randomized phase III trial of personalized peptide vaccination for castration‑resistant prostate cancer progressing after docetaxel.
5/2020Mixed 20-peptide cancer vaccine in combination with docetaxel and dexamethasone for castration-resistant prostate cancer: a randomized phase II trial.
1/2020Identification of biomarkers for personalized peptide vaccination in 2,588 cancer patients.
1/2019A randomized, double-blind, phase III trial of personalized peptide vaccination for recurrent glioblastoma.
9/2018Survival analysis of multiple peptide vaccination for the selection of correlated peptides in urological cancers.
3/2018Antitumor activity of antibody against cytotoxic T lymphocyte epitope peptide of lymphocyte-specific protein tyrosine kinase.
12/2017Personalized peptide vaccination as second-line treatment for metastatic upper tract urothelial carcinoma.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kyogo Itoh Research Topics

Disease

122Neoplasms (Cancer)
06/2022 - 01/2002
53Prostatic Neoplasms (Prostate Cancer)
01/2021 - 07/2003
10Pancreatic Neoplasms (Pancreatic Cancer)
02/2021 - 01/2002
9Colonic Neoplasms (Colon Cancer)
11/2020 - 05/2002
9Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2017 - 07/2004
8Breast Neoplasms (Breast Cancer)
06/2022 - 07/2004
7Colorectal Neoplasms (Colorectal Cancer)
05/2015 - 03/2002
7Melanoma (Melanoma, Malignant)
04/2015 - 07/2003
7Glioma (Gliomas)
08/2008 - 08/2005
6Stomach Neoplasms (Stomach Cancer)
09/2019 - 09/2003
6Carcinoma (Carcinomatosis)
12/2017 - 03/2002
6Neoplasm Metastasis (Metastasis)
07/2014 - 02/2004
5Disease Progression
01/2021 - 08/2003
5Adenocarcinoma
09/2019 - 04/2004
5Uterine Cervical Neoplasms (Cancer of the Cervix)
09/2015 - 01/2004
5Lung Neoplasms (Lung Cancer)
01/2013 - 09/2002
5Infections
09/2008 - 01/2004
5Renal Cell Carcinoma (Grawitz Tumor)
12/2007 - 06/2003
4Hepatocellular Carcinoma (Hepatoma)
09/2017 - 11/2006
4Ovarian Neoplasms (Ovarian Cancer)
01/2017 - 06/2003
4Hypersensitivity (Allergy)
05/2005 - 01/2002
3Triple Negative Breast Neoplasms
08/2020 - 07/2014
3Biliary Tract Neoplasms (Biliary Tract Cancer)
05/2017 - 03/2012
3Kidney Neoplasms (Kidney Cancer)
06/2011 - 10/2005
2Adenocarcinoma of Lung
06/2022 - 06/2003
2Liver Cirrhosis (Hepatic Cirrhosis)
07/2019 - 04/2002
2Glioblastoma (Glioblastoma Multiforme)
01/2019 - 01/2011
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
11/2017 - 04/2012
2Gastrointestinal Neoplasms (Gastrointestinal Cancer)
05/2016 - 05/2002
2Esophageal Neoplasms (Esophageal Cancer)
01/2016 - 04/2015
2Sarcoma (Soft Tissue Sarcoma)
10/2013 - 01/2004
2Testicular Neoplasms (Testicular Cancer)
07/2013 - 06/2012
2Anemia
01/2013 - 07/2007
2Squamous Cell Carcinoma of Head and Neck
09/2012 - 02/2004
2Injection Site Reaction
01/2011 - 01/2011
2Hypercalcemia (Milk Alkali Syndrome)
10/2005 - 02/2005

Drug/Important Bio-Agent (IBA)

155Peptides (Polypeptides)IBA
06/2022 - 01/2002
55AntigensIBA
08/2021 - 01/2002
39Protein Subunit VaccinesIBA
08/2021 - 03/2002
35Immunoglobulin G (IgG)IBA
08/2021 - 01/2002
32EpitopesIBA
08/2021 - 01/2002
29Cancer VaccinesIBA
06/2022 - 06/2003
29VaccinesIBA
08/2020 - 01/2002
22HLA Antigens (Human Leukocyte Antigens)IBA
01/2019 - 01/2004
20Proteins (Proteins, Gene)FDA Link
09/2015 - 01/2002
15HLA-A2 Antigen (HLA A2 Antigen)IBA
11/2015 - 05/2002
14HLA-A24 AntigenIBA
09/2010 - 06/2003
13Biomarkers (Surrogate Marker)IBA
01/2020 - 02/2004
12Messenger RNA (mRNA)IBA
03/2007 - 06/2003
9Hormones (Hormone)IBA
03/2010 - 09/2003
8Prostate-Specific Antigen (Semenogelase)IBA
08/2021 - 08/2003
8EstramustineFDA Link
04/2011 - 02/2004
7HLA-A3 Antigen (HLA A3 Antigen)IBA
09/2010 - 02/2004
6Phosphates (Orthophosphate)IBA
04/2011 - 02/2004
5PlatinumIBA
12/2017 - 09/2007
5HLA-A Antigens (HLA-A)IBA
09/2015 - 02/2009
5HLA-A*33 antigenIBA
02/2009 - 02/2004
5AntibodiesIBA
07/2007 - 01/2002
4Docetaxel (Taxotere)FDA Link
01/2021 - 06/2012
4CytokinesIBA
01/2015 - 08/2005
4Complementary DNA (cDNA)IBA
07/2013 - 02/2002
4Neoplasm Antigens (Tumor Antigens)IBA
07/2013 - 06/2002
4HLA-A11 AntigenIBA
02/2009 - 02/2004
4HLA-A31 antigenIBA
02/2009 - 02/2004
4Immunoglobulin E (IgE)IBA
09/2008 - 01/2002
3Dexamethasone (Maxidex)FDA LinkGeneric
05/2020 - 12/2008
3prostatic acid phosphataseIBA
09/2018 - 09/2004
3HaptoglobinsIBA
02/2017 - 01/2013
3HLA-A*26 antigenIBA
10/2015 - 11/2009
3ErythropoietinFDA Link
04/2015 - 05/2008
3Gefitinib (Iressa)FDA Link
01/2014 - 07/2004
3ErbB Receptors (EGF Receptor)IBA
01/2014 - 07/2004
3Tyrosine Kinase InhibitorsIBA
01/2014 - 07/2004
3Polycomb-Group ProteinsIBA
11/2007 - 09/2004
3Amino AcidsFDA Link
08/2005 - 05/2002
2Biological ProductsIBA
03/2018 - 05/2004
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
03/2018 - 04/2015
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
05/2017 - 02/2016
2Immunologic Factors (Immunomodulators)IBA
01/2017 - 05/2004
2Immune Checkpoint InhibitorsIBA
01/2017 - 05/2013
2Interleukin-6 (Interleukin 6)IBA
01/2013 - 03/2012
2TubulinIBA
09/2010 - 06/2009
2GemcitabineFDA Link
09/2010 - 04/2007
2Gonadotropin-Releasing Hormone (GnRH)FDA Link
03/2010 - 02/2004
2Immunoglobulin A (IgA)IBA
09/2008 - 06/2008
2Enhancer of Zeste Homolog 2 ProteinIBA
11/2007 - 09/2004
2Androgen Receptors (Androgen Receptor)IBA
08/2007 - 11/2006
2Fluorouracil (Carac)FDA LinkGeneric
07/2007 - 09/2004
2Tumor Biomarkers (Tumor Markers)IBA
04/2007 - 02/2006
2Monomeric GTP-Binding ProteinsIBA
04/2007 - 10/2004
2KinesinsIBA
03/2007 - 06/2005
2InterferonsIBA
03/2007 - 07/2003
2Parathyroid Hormone-Related ProteinIBA
10/2005 - 02/2005

Therapy/Procedure

65Immunotherapy
11/2020 - 01/2002
23Drug Therapy (Chemotherapy)
11/2020 - 10/2006
21Therapeutics
09/2017 - 02/2004
19Castration
05/2020 - 03/2010
3Prostatectomy (Retropubic Prostatectomy)
04/2015 - 06/2007
3Oral Administration
11/2009 - 11/2006
2Aftercare (After-Treatment)
01/2013 - 06/2012